SomaGenics’ Strengthens Its IP and Technology Position in Small RNA Analysis and Biomarker Discovery With New Patent and Publication
SANTA CRUZ, Calif., Sept. 18, 2018 /PRNewswire/ — SomaGenics, a biotechnology company focused on developing lowest bias sequencing and highest specificity RT-qPCR technologies for small RNAs, announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative,... Read more